Can sulphonylurea addition to lifestyle changes help to delay diabetes development in subjects with impaired fasting glucose? The Nepi ANtidiabetes StudY (NANSY) - Lindblad, U.; Lindberg, G.; Månsson, N.-O.; Ranstam, J.; Tyrberg, M.; Jansson, S.; Lindwall, K.; Svärdh, M.; Kindmalm, L.; Melander, A. (Diabetes, obesity & metabolism, 2011)
Keywords: Adult; Aged; Clinical Medicine; Diabetes; Diabetes mellitus (non-insulin dependent); Diabetes Mellitus, Type 2 - drug therapy; Diabetes Mellitus, Type 2 - prevention & control; Endocrinology and Diabetes; Endokrinologi och diabetes; Fasting; Female; Humans; IFG; Klinisk medicin; Male; Medical and Health Sciences; Medicin och hälsovetenskap; Middle Aged; Placebos; Prediabetic State - drug therapy; prevention; Primary care; randomized trial; Retinopathy; Risk Reduction Behavior; Sulfonylurea Compounds - therapeutic use; sulphonylurea; type 2; type 2 diabetes